Transcatheter Valve

William Blair analysts Ben Andrew and Alexa Desai expressed more confidence on Edwards Lifesciences Corporation (NYSE: EW) as they believe the durability concerns were overdone based on Transcatheter Valve Therapies (TVT). The brokerage has an Outperform rating on shares. William Blair noted...